Beatriz Aguado

872 total citations
22 papers, 215 citations indexed

About

Beatriz Aguado is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Beatriz Aguado has authored 22 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Beatriz Aguado's work include Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Beatriz Aguado is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer Treatment and Pharmacology (3 papers). Beatriz Aguado collaborates with scholars based in Spain, United States and Mexico. Beatriz Aguado's co-authors include Adrían Alegre, Rafael de la Cámara, Jesús F. San Miguel, Atanasio Pandiella, David P. Schenkein, Azucena Esparís‐Ogando, Albert Oriol, Joan Bladé, Norma C. Gutiérrez and Gema Mateo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Beatriz Aguado

20 papers receiving 214 citations

Peers

Beatriz Aguado
Comparison fields: 5 of 47
  • Hematology 127
  • Oncology 92
  • Molecular Biology 82
  • Genetics 40
  • Surgery 28
Sigrún Þorsteinsdóttir Denmark
Bita Fakhri United States
F. W. Cremer Germany
Alessandra Cupri Italy
Kenji Nara Japan
Luděk Pour Czechia
Victoria R. Alegria United States
Chantiya Chanswangphuwana Thailand
Peter Noellke Germany
Arne Trummer Germany
Sigrún Þorsteinsdóttir Denmark View profile →
Citations per field, relative to Beatriz Aguado
Beatriz Aguado · 1×
Citations per year, relative to Beatriz Aguado
Beatriz Aguado · 1×

Countries citing papers authored by Beatriz Aguado

Since Specialization
Citations

This map shows the geographic impact of Beatriz Aguado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Aguado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Aguado more than expected).

Fields of papers citing papers by Beatriz Aguado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Aguado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Aguado. The network helps show where Beatriz Aguado may publish in the future.

Co-authorship network of co-authors of Beatriz Aguado

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Aguado. A scholar is included among the top collaborators of Beatriz Aguado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Aguado. Beatriz Aguado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Whole-body MRI Versus [18F]FDG PET/CT in Diagnosing and Monitoring Plasmacytomas Clinical Nuclear Medicine Nieves Gómez León, Beatriz Aguado et al. 0
2 Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation European Journal Of Haematology Mireia Morgades, Carlos Pinho Vaz et al. 4
3 Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma Clinical Nuclear Medicine Nieves Gómez León, Beatriz Aguado et al. 14
4 TYK2 Variants in B-Acute Lymphoblastic Leukaemia Genes Irene Bodega‐Mayor, Francisca Molina‐Jiménez et al. 7
5 Can COVID‐19 cause severe neutropenia? SHILAP Revista de lepidopterología Rafael de la Cámara, Laura Cardeñoso et al. 18
6 Retrospective comparison between COBE SPECTRA and SPECTRA OPTIA apheresis systems for hematopoietic progenitor cells collection for autologous and allogeneic transplantation in a single center Journal of Clinical Apheresis Adrián Alegre Amor, Beatriz Aguado et al. 5
7 Cutaneous involvement as the first manifestation of T‐lymphoblastic lymphoma and review of the literature Journal of Cutaneous Pathology Mar Llamas‐Velasco, Beatriz Aguado et al. 7
8 Multiple myeloma patients in long-term complete response after autologous stem cell transplantation express a particular immune signature with potential prognostic implication Bone Marrow Transplantation Ana Arteche‐López, Anna Kreutzman et al. 21
9 Dynamics of Hemorragic Events and Primary Hemostasis Deffects during Treatment with Ibrutinib. Real-Life Experience Blood Javier Loscertales, Beatriz Aguado et al. 1
10 Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience Leukemia & lymphoma Adrían Alegre, Albert Oriol et al. 19
11 Preliminary Experience of the Spanish Compassionate Use Registry of Bendamustine in Patients with Relapsed and/or Refractory Multiple Myeloma Blood Beatriz Aguado, Felipe de Arriba et al. 2
12 Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma Clinical Medicine Insights Oncology Adrían Alegre, Beatriz Aguado et al. 7
13 Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients International Journal of Hematology Adrían Alegre, Beatriz Aguado et al. 15
14 Extramedullary plasmacytomas in the context of multiple myeloma Advances in Therapy Beatriz Aguado, J. Sastre et al. 8
15 Mid term results after bone marrow laser revascularization for treating refractory angina BMC Cardiovascular Disorders Guillermo Reyes, Keith B. Allen et al. 11
16 Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease☆ European Journal of Cardio-Thoracic Surgery Guillermo Reyes, Keith B. Allen et al. 5
17 Clinical Efficacy of Bortezomib Based Therapy in Plasma Cell Leukemias. Blood Adrían Alegre, Beatriz Aguado et al. 1
18 Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases Revista Española de Enfermedades Digestivas Javier P. Gisbert, Beatriz Aguado et al. 11
19 Pulmonary embolism in a patient with severe congenital deficiency for factor V during treatment with fresh frozen plasma Haemophilia Ana García‐Noblejas, Sonia Osorio et al. 12
20 Bortezomib is an efficient agent in plasma cell leukemias International Journal of Cancer Azucena Esparís‐Ogando, Adrían Alegre et al. 44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026